Why the study?
Data on the long-term durability of weight loss and comorbidity resolution beyond 7 years after laparoscopic sleeve gastrectomy in adolescents were completely lacking.
Does laparoscopic sleeve gastrectomy improve long-term anthropometric and cardiometabolic outcomes in adolescents?
Does laparoscopic sleeve gastrectomy improve long-term anthropometric and cardiometabolic outcomes in adolescents?
Laparoscopic sleeve gastrectomy in adolescents achieves substantial and sustained weight loss and remission of cardiometabolic risk factors up to 9 years post-surgery.
Answers are grounded in this paper and cite their sources.
Supports sustained cardiometabolic benefits after adolescent LSG to 9 years; leaves open need for prospective trials to guide practice.
Background Long-term durability of weight loss and comorbidity resolution beyond 7 years after laparoscopic sleeve gastrectomy (LSG) among adolescents is completely lacking. Methods Retrospective review of adolescents aged ≤ 18 years who underwent primary LSG at our institution between 2011 and 2015 ( N = 146). We assessed anthropometric and cardiometabolic outcomes at 1, 3, 5, 7, and 9 years. Results Follow-up rates were 57.53%, 82.87%, 85.24%, 83.92%, and 83.33% at the five time points. The preoperative mean body mass index (BMI) (45.60 ± 6.50 kg/m 2 ) decreased at year 1 (30.04 ± 4.96 kg/m 2 , P =0.001) and was maintained up to 9 years (30.20 ± 3.92 kg/m 2 , P = 0.001). Remission rates were triglycerides, 100% (11/11) at 5 years, and 100% (1/1) at 9 years; high density lipoprotein, 89.4% (17/19) at 5 years, and 100% (3/3) at 7 years; low density lipoprotein, 71.4% (11/14) and 100% (3/3) at 5 and 7 years; total cholesterol, 70% (7/10) at 5 years, and 100% (2/2) at 9 years; uric acid, 100% (3/3) at 5 years. Remission of liver enzymes was 84.6–100% (22/26–2/2) at 5–9 years. Prediabetes remission was 87.5% (14/16 and 7/8) at 5 and 7 years and 100% (3/3) at year 9. Type 2 diabetes complete remission was 50% (3/6, 1/2) at years 5 and 7, with all cases resolved at 9 years. The only case of hypertension completely resolved. Conclusions LSG achieved substantial weight loss and remission of cardiometabolic risk factors that were sustained on the long term. This is the first study among adolescents to assess such outcomes beyond 7 years.
No takes yet. Share an insight, caveat, or question.
Elhag et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: